These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24511032)

  • 21. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
    Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
    Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study.
    Huang CM; Lv CB; Lin JX; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Cao LL; Lin M; Tu RH
    Surg Endosc; 2017 Sep; 31(9):3495-3503. PubMed ID: 27981384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adenocarcinoma of the esophagogastric junction: retrospective analysis of 39 patients].
    Butte JM; Becker F; Visscher A; Waugh E; Meneses M; Court I; Parada H; DE LA Fuente H
    Rev Med Chil; 2010 Jan; 138(1):53-60. PubMed ID: 20361151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological Characteristics and Prognostic Factors of Patients with Siewert Type II Esophagogastric Junction Carcinoma: A Retrospective Multicenter Study.
    Matsuda T; Kurokawa Y; Yoshikawa T; Kishi K; Misawa K; Ohi M; Mine S; Hiki N; Takeuchi H
    World J Surg; 2016 Jul; 40(7):1672-9. PubMed ID: 26928855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 27. Should the splenic hilar lymph node be dissected for the management of adenocarcinoma of the esophagogastric junction?
    Kumazu Y; Hasegawa S; Hayashi T; Yamada T; Watanabe H; Hara K; Shimoda Y; Nakazono M; Nagasawa S; Rino Y; Masuda M; Ogata T; Oshima T; Yoshikawa T
    Eur J Surg Oncol; 2023 Jan; 49(1):76-82. PubMed ID: 35868951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of laparoscopic-assisted and open total gastrectomy for Siewert Types II and III adenocarcinoma of the esophagogastric junction.
    Wang J; Wang JC; Song B; Dai XD; Zhang XY
    J Cell Physiol; 2019 Jul; 234(7):11235-11239. PubMed ID: 30478913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of efficacy between laparoscopic and open proximal gastrectomy with double-tract reconstruction for Siewert type Ⅱ and Ⅲ adenocarcinoma of the esophagogastric junction].
    Ma F; Peng LQ; Liu CP; Zhang YL; Wang L; Zhang B; Ma Q; Ji SQ; Chai JH; Tang XC; Zhao EJ; Hua YW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):420-425. PubMed ID: 34000771
    [No Abstract]   [Full Text] [Related]  

  • 30. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction.
    Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Yamaguchi T
    Br J Surg; 2013 Jul; 100(8):1050-4. PubMed ID: 23754647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers.
    Hölscher AH; Law S
    Gastric Cancer; 2020 Jan; 23(1):3-9. PubMed ID: 31691875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
    Haverkamp L; Seesing MF; Ruurda JP; Boone J; V Hillegersberg R
    Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27001442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of laparoscopic total gastrectomy for advanced Siewert type Ⅱ and type Ⅲ esophagogastric junction carcinoma: A propensity score-matched case-control study.
    Zhao Y; Zhang J; Yang D; Tang Z; Wang Q
    Asian J Surg; 2019 Aug; 42(8):805-813. PubMed ID: 30685144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Surgical strategy for adenocarcinoma of esophagogastric junction].
    Lu Y; Zhang K; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):107-111. PubMed ID: 30799532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of transabdominal and transthoracic surgical approaches in the treatment of Siewert type II esophagogastric junction cancers: A propensity score-matching analysis.
    Oh SE; Lee GH; An JY; Lee JH; Sohn TS; Bae JM; Kim S; Choi MG
    Eur J Surg Oncol; 2022 Feb; 48(2):370-376. PubMed ID: 34433514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of Siewert type II adenocarcinoma of the esophagogastric junction: the perspectives from thoracic surgery].
    Li ZY; Gu YM; Wang WP; Chen LQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):109-113. PubMed ID: 35176820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of spleen-preserving lymphadenectomy in total gastrectomy for gastric and esophagogastric junctional adenocarcinomas: A long-term retrospective propensity score match study from a high-volume institution in China.
    Liu K; Chen XZ; Zhang YC; Zhang WH; Chen XL; Sun LF; Yang K; Zhang B; Zhou ZG; Hu JK
    Surgery; 2021 Feb; 169(2):426-435. PubMed ID: 32950240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphadenectomy around the left renal vein in Siewert type II adenocarcinoma of the oesophagogastric junction.
    Mine S; Sano T; Hiki N; Yamada K; Nunobe S; Yamaguchi T
    Br J Surg; 2013 Jan; 100(2):261-6. PubMed ID: 23180514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.